Will Palpal exceed Cialis? The industry has paid attention on impotence treatments

The industry concerned paid attention on the Palpal’s (Hanmi Pharmaceutical) direction to exceed over the top impotence treatment ‘Cialis’.

In various indexes, there is higher possibility Palpalwill take the lead. The patent expiration of Cialis on September can be a chance to Palpal.

According to the industry concerned on the 27^th, the UBIST data showed that Palpal with KRW 24.7 billion has ...